Showing results for:
Asparaginase erwinia chrysanthemi (recombinant)- rywn
Drug name(s)
Asparaginase erwinia chrysanthemi (recombinant)- rywn Rylaze®
Approved for
- Acute Lymphoblastic Leukemia (ALL)
- Lymphoblastic Lymphoma
Drug name(s)
Rezurock™ Belumosudil
Approved for
- Other Blood Cancers
Drug name(s)
Rolvedon™ Eflapegrastim-xnst
Approved for
- Other Blood Cancers
Drug name(s)
Epogen® Procrit® EPO Epoetin alfa Epoetin alfa-epbx* Retacrit™ *
Approved for
- Other Blood Cancers
Drug name(s)
Neupogen® Filgrastim G-CSF Zarxio™ * Filgrastim-sndz* Nivestym™ * Filgrastim-aafi* Releuko* Filgrastim-ayow*
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
- Other Blood Cancers
Drug name(s)
Rytelo Imetelstat
Approved for
- Myelodysplastic Syndromes (MDS)
Drug name(s)
Roferon®-A Interferon alfa-2a
Approved for
- Chronic Myeloid Leukemia (CML)
- Hairy Cell Leukemia (HCL)
- Other Blood Cancers
Drug name(s)
Revlimid® Lenalidomide
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Myeloma
- Myelodysplastic Syndromes (MDS)
Drug name(s)
Reblozyl® Luspatercept-aamt
Approved for
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPN)
Drug name(s)
Rheumatrex® Trexall® Methotrexate
Approved for
- Leukemia
- Acute Lymphoblastic Leukemia (ALL)
- Non-Hodgkin Lymphoma (NHL)
- Other Blood Cancers
Drug name(s)
Rydapt® Midostaurin
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
- Other Blood Cancers
Drug name(s)
Olutasidenib Rezlidhia™
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
Drug name(s)
Elitek® Rasburicase
Approved for
- Leukemia
- Lymphoma
Drug name(s)
Ryoncil® Remestemcel-L-rknd
Drug name(s)
Revumenib Revuforj®
Approved for
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
Drug name(s)
Rituxan® Rituximab Truxima® * Rituximab-abbs* Ruxience™ * Rituximab-pvvr* Riabni Rituximab-arrx*
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- B-Cell Prolymphocytic Leukemia
- Lymphoma
- Non-Hodgkin Lymphoma (NHL)
- Burkitt Lymphoma (BL)
- Diffuse Large B-cell Lymphoma (DLBCL)
Rituximab and hyaluronidase human
Drug name(s)
Rituxan Hycela® Rituximab and hyaluronidase human
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
Drug name(s)
Istodax® Romidepsin
Approved for
- Lymphoma
- Cutaneous T-cell Lymphoma (CTCL)
Drug name(s)
Ropeginterferon alfa-2b-njft Besremi®
Approved for
- Polycythemia Vera
Drug name(s)
Jakafi® Ruxolitinib
Approved for
- Essential Thrombocythemia
- Primary Myelofibrosis
- Polycythemia Vera